Objective: Digital subtraction angiography (DSA) of the peripheral arterial vasculature provides lumenographic information but only a qualitative assessment of blood flow. The ability to quantify adequate tissue perfusion of the lower extremities would enable real-time perfusion assessment during DSA of patients with peripheral arterial disease (PAD). In this study, we used a novel real-time imaging software to delineate tissue perfusion parameters in the foot in PAD patients.
Evaluation for peripheral arterial disease (PAD) can be accomplished through several noninvasive measures. The ankle-brachial index (ABI) has been validated against contrast angiography to yield sensitivity of 79% to 95% and specificity of 96% to 100% in predicting a 50% stenosis. [1] [2] [3] Although it is a useful screening tool, it cannot be used during angiography to provide realtime objective feedback to the operator about treatment efficacy. In addition, ABIs are not accurate in patients with noncompressible vessels, such as those often seen in diabetics, and it cannot localize diseased vasculature in the foot.
Whereas noninvasive testing provides objective data with prognostic value, contrast angiography is the "gold standard" for evaluating vascular anatomy. Angiography in conjunction with digital subtraction permits a subjective visual assessment of intraluminal vessel diameter and flow down the limb while allowing concurrent endovascular interventions. 4 However, visualization with this approach is limited in small vessels distal to the knee and in settings of poor inflow. 5 Furthermore, visual assessment of flow is dependent on the operator's judgment and thus may be inconsistent across operators. The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
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Copyright Two-dimensional perfusion (2DP) imaging is one tool that may address this deficit. It is a postprocessing software that color codes the flow of contrast material using digital subtraction angiography (DSA) images. As contrast material flows through a specified region of interest (ROI), the 2DP software detects an increased pixel density, or signal intensity (SI), and extrapolates quantitative information by generating SI curves within the ROI. This allows the operator to make rapid assessment of perfusion during angiography without the need for additional DSA runs. The 2DP tool allows measurements of six different parameters, some of which include arrival time (AT), time to peak signal density (TTP), the rate of contrast material wash-in (WIR), and overall signal density in the area (Table I ). In addition to intraoperative analysis, a second look can also be conducted at a workstation after the procedure. It has been previously used in analysis of cerebral flow after an intervention [6] [7] [8] [9] and in the peripheral vasculature. [10] [11] [12] [13] [14] Here in a prospective study, we sought to determine the feasibility of using the 2DP (Philips Healthcare, Andover, Mass) color-coded angiography to measure hemodynamic changes in the lower extremities after an endovascular intervention in patients with known PAD. We hypothesize that because contrast material would move more slowly down an extremity with severe PAD, two-dimensional (2D) parameters that reflect transit time, such as AT, transit time down the leg, and TTP, would increase, whereas parameters reflecting volume or velocity, such as SI, area under the curve (AUC), and WIR, would decrease.
METHODS
Patient enrollment. Enrollment occurred from March 2015 to June 2016. After Institutional Review Board approval, patients undergoing lower extremity angiography for PAD as demonstrated on a noninvasive vascular laboratory study or for symptoms of claudication, rest pain, or minor tissue loss were approached for this study and enrolled after written consent. Exclusion criteria included presence of renal dysfunction (creatinine concentration >2.5 mg/dL) that did not require dialysis and history of previous foot amputations. After the patient was enrolled, an ABI of the affected limb was performed before the procedure. This ABI was either obtained at an accredited vascular laboratory or performed manually by the study team at the time of encounter. After intervention, another ABI was obtained immediately postoperatively. Preintervention demographic and clinical characteristics data were captured and are outlined in Table II , A and B, for the entire cohort and the preintervention vs postintervention cohort, respectively. Our power calculation demonstrated 0.8 power with an effect size of 0.5 and a significance level of .05, requiring 31 patients for enrollment.
2DP protocol. The 2DP software provides measurements of six different parameters, characterizing the change in contrast SI over time within an ROI. AT is the time between the start of DSA and the detection of contrast material within the ROI. TTP is the time between the first detection of contrast material and the peak SI, and WIR is the slope of the SI curve. These three parameters help elucidate the briskness of blood flow down the lower extremity. The total volume of blood reaching Recommendation:
The study suggests that twodimensional perfusion imaging may be a useful software tool to assess effectiveness immediately after intervention for peripheral arterial disease.
the target is indirectly represented by the AUC, roughly signifying the overall volume of contrast material observed within the ROI. Finally, width and mean transit time (MTT) evaluate the time for contrast material to travel through an ROI (Fig 1) . On occasion, a delay is specified between the moment contrast material is injected down the leg to the start of DSA acquisition. Hence, a derived parameter called the leg transit time (LTT) was created to represent the travel time from the catheter tip to the first detection of the contrast material in the foot. The peak SI within the ROI was also noted with each run.
With severe PAD causing contrast material to move slowly down the leg, parameters such as AT, LTT, TTP, width, and MTT were anticipated to increase. However, WIR, peak, and AUC were expected to decrease.
Image acquisition. In the operating room, the patient's foot was stabilized in a foam footrest to minimize movement artifacts. A radiopaque ruler was placed across the inguinal ligament along the upper leg as a reference for the catheter tip's position in the common femoral artery. Following a contralateral femoral retrograde access, a 5F glide catheter was positioned approximately 2 cm proximal to the branching of the profunda femoris. Standard diagnostic DSA images of the lower extremity were obtained, through the thigh, knee, lower leg, and foot. With the foot serving as the area of interest, a 2DP image was obtained at 3 frames/s by selecting the protocol before the DSA run. Contrast agent injection settings were standardized across patients (full-strength iodixanol [Visipaque], injection rate of 3 mL/s for 9 mL and pressure of 600 psi). If an intervention was performed after the diagnostic angiography, a postintervention 2DP image was also obtained with the same C-arm angulation and table position as for the preintervention image. The distance from the catheter tip to the patient's medial malleolus was measured and documented to account for anatomic differences in leg length among patients.
Data analysis. The ROI for 2D image analysis was taken as a small circular selection overlying the most robust tibial or peroneal artery at the level of the medial malleolus. This selection reduced distortion of the SI curve by noise and served as an estimate of the amount of perfusion to the foot.
The correlation between grouping of ABI ranges and the 2D parameters was analyzed using one-way analysis of variance. Any change to the 2D parameters before and after an intervention was analyzed using Wilcoxon matched-pairs signed rank test. A P value of < .05 was considered statistically significant. Linear regression was used to evaluate the relationship between the ABI and the 2D parameters.
RESULTS
Thirty-one patients were enrolled and 36 procedures were performed. Eighteen of these procedures included an intervention with either angioplasty or stenting, from which preintervention and postintervention 2D DSA images were obtained; 14 limbs were classified as Rutherford category 5, 11 limbs as category 4, and 9 limbs as category 3. There were 19 male patients and 12 female patients. A total of 54 2D DSA images were obtained. Preinterventional perfusion parameters demonstrated wide ranges across the entire cohort of patients as outlined in Table III . In particular, the AUC, peak intensity, and WIR varied greatly with interquartile range differences of 10,319.9 SI*s, 524.25 SI, and 42.9 SI/s, respectively. Each 2D DSA run was allocated into four groups according to the measured ABI recorded for that session.
If an intervention was performed during the session, the 2D parameters before an intervention were associated with its preoperative ABI; the 2D measurements obtained after an intervention were grouped with the postoperative ABI. Of 54 DSA runs (including diagnostic, preintervention, and postintervention runs) obtained with 2DP, 10 were excluded because of inability to obtain an ABI (ie, calcified vessels or poor follow-up) and 6 because of protocol deviation. There were 9 DSA runs With worsening ABI, 2D parameters responded as predicted. There was an increase in LTT from 6.81 seconds in patients with an ABI between 0.91 and 1.2 to 12.65 seconds in patients with ABI between 0.00 and 0.40 (P ¼ .02). There was also a trend toward prolonged AT, LTT, TTP, width, and MTT with increasing disease severity. The rate at which contrast material washed in (WIR), the AUC seen in the ROI, and the peak SI did decrease, but this change was not statistically significant (Table IV; Fig 3) .
Eighteen of the procedures (16 patients) during the study period were cases involving angioplasty either with or without stent placement. To determine if there were any detectable changes in the 2D flow parameters after an intervention, differences in flow parameters were compared with those in preintervention vs postintervention ABI. Six of the DSA studies were excluded for this analysis comparing ABI. Four angiographic studies were excluded because the patient's calcified vessels precluded obtaining accurate ABIs, and two were excluded because a postoperative ABI could not be obtained on follow-up.
Change in 2D parameters across the 18 procedures after an intervention was analyzed. After an intervention, most 2D parameters with the exception of AUC had changes that were statistically significant. Flow parameters characterizing the speed of the contrast agent's traveling down the leg and into the foot, such as AT, LTT, TTP, width, and MTT, all decreased after intervention (Fig 4) . For example, average AT shortened from 5.35 to 3.35 seconds (P ¼ .003). WIR increased significantly as well, increasing from 82.81 to 121.9 SI/s (P ¼ .004).
The 2D parameters appeared to trend in the appropriate direction after angioplasty with or without stenting; however, on further analysis, correlation between the degree of change in 2D parameters and the degree of change in the ABI was not significant. For example, an improvement in ABI of about 15% can result in changes in AT that vary from 7% to 78%.
DISCUSSION
Conventional DSA of the peripheral arteries establishes disease severity while providing the opportunity for therapeutic intervention and subsequent imaging for treatment efficacy. With digital subtraction, this modality delineates intraluminal flow clearly but allows only qualitative evaluation of tissue perfusion. The ability to determine adequate perfusion through small vessels of distal tissue is especially affected. 15 More noninvasive physiologic tests, such as Doppler ultrasound or ABI, allow an objective examination of arterial flow, and they can be performed serially postoperatively to monitor disease progression. However, these methods cannot be a N reflects number of two-dimensional perfusion (2DP) angiograms included for this analysis, 14 of which were diagnostic angiograms and 18 were preintervention angiograms. performed intraoperatively to guide the revascularization plan. In addition, the ABI is limited in that measurements have been shown to vary between technicians and across consecutive measurements, 16 and it cannot visualize pedal microvasculature to assess healing of foot wounds. New innovations in imaging, such as 2DP, not only allow visualization of the anatomy but also provide functional information on tissue perfusion. There have been several studies assessing the feasibility of using 2D imaging in detecting changes to perfusion after intervention in the brain [6] [7] [8] and in the peripheral vasculature. [10] [11] [12] [13] [14] This study attempts to validate the 2DP tool in a prospective manner. This study showed that improved flow to distal tissue is reflected by measurable changes in 2DP parameters. Across our study patients, we saw a trend toward longer AT, LTT, width, and MTT with increased disease severity as well as decreased WIR, SI, and AUC. In addition, we also saw a statistically significant difference in preintervention vs postintervention curves, for which there was a shortened AT, LTT, and TTP after angioplasty with or without stenting. On the other hand, parameters such as WIR acquired a steeper slope, and peak SI increased. A limitation of the 2DP parameters is the wide variation across patients. This may be due to factors such as anatomic or physiologic differences (ie, blood pressure or volume status) between patients. Furthermore, the perfusion parameters are generated on the basis of various measurements of contrast agent travel time and are influenced by the distance at which the contrast material has to travel. Thus, stringent standardization protocols outlining catheter placement, contrast agent injection, and imaging fields must be followed for each data capture to ensure that sequential 2DP runs are comparable within a patient. Assignment of the ROI placement and DSA frame selection within the software must be identical for preintervention and postintervention acquisitions to accurately capture any change in perfusion parameters after an intervention. In addition, poor outflow may limit the washout of contrast material and diminish the validity of the width, MTT, and AUC parameters. Finally, the ideal ROI to assess true foot perfusion should include the small vessels of the whole feet. The ROI for this study was drawn over the most robust artery at the ankle, serving as an indicator of perfusion to the distal foot, because noise in the forefoot precluded a bigger selection. This noise may have been a result of overlapping bones in the feet or toe movement. A lateral foot view may resolve this issue and allow a larger selection.
Our findings suggest that the 2DP technique may be useful for predicting clinical outcomes. The quest for quantitative thresholds for healing of ischemic wounds and resolution of PAD symptoms using this system warrants further study.
CONCLUSIONS
The 2DP imaging may be a clinically useful adjunct in assessing treatment efficacy for patients with PAD in that it provides a quantitative assessment of hemodynamic changes after endovascular intervention. We observed that the parameters extrapolated from the 2DP image processing software tend to reflect improvements in blood flow in a predictable mannerd measurements of contrast material travel time decrease, whereas measurements of volume increase. In addition to providing intraoperative feedback, 2DP may be more sensitive than the ABI in capturing changes in flow and useful in evaluating overall perfusion within a given ROI. Our experience with the 2DP software has shown that this technique may provide valuable insight into whether an intervention is sufficient for limb salvage. 
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